| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 228.64% | Baird | → $7 | Initiates Coverage On | → Outperform |
| 05/18/2023 | 369.48% | Maxim Group | $8 → $10 | Maintains | Buy |
| 08/03/2021 | 289.67% | Ladenburg Thalmann | → $8.3 | Initiates Coverage On | → Buy |
What is the target price for Immutep (IMMP)?
The latest price target for Immutep (NASDAQ: IMMP) was reported by Baird on August 2, 2023. The analyst firm set a price target for $7.00 expecting IMMP to rise to within 12 months (a possible 228.64% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Immutep (IMMP)?
The latest analyst rating for Immutep (NASDAQ: IMMP) was provided by Baird, and Immutep initiated their outperform rating.
When is the next analyst rating going to be posted or updated for Immutep (IMMP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immutep, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immutep was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
Is the Analyst Rating Immutep (IMMP) correct?
While ratings are subjective and will change, the latest Immutep (IMMP) rating was a initiated with a price target of $0.00 to $7.00. The current price Immutep (IMMP) is trading at is $2.13, which is within the analyst's predicted range.
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 228.64% | Baird | → $7 | Initiates Coverage On | → Outperform |
| 05/18/2023 | 369.48% | Maxim Group | $8 → $10 | Maintains | Buy |
| 08/03/2021 | 289.67% | Ladenburg Thalmann | → $8.3 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/02/2023 | 228.64% | 貝爾德 | →$7 | 開始承保 | →跑贏大盤 |
| 2023年05月18日 | 369.48% | Maxim集團 | $8→$10 | 維護 | 買 |
| 08/03/2021 | 289.67% | 拉登堡·塔爾曼 | →$8.3 | 開始承保 | →購買 |
What is the target price for Immutep (IMMP)?
Immutep(IMMP)的目標價是多少？
The latest price target for Immutep (NASDAQ: IMMP) was reported by Baird on August 2, 2023. The analyst firm set a price target for $7.00 expecting IMMP to rise to within 12 months (a possible 228.64% upside). 2 analyst firms have reported ratings in the last year.
貝爾德於2023年8月2日報道了Immutep(納斯達克代碼：IMMP)的最新目標價。這家分析公司將目標價定為7美元，預計IMMP將在12個月內上漲(可能上漲228.64%)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Immutep (IMMP)?
Immutep(IMMP)的最新分析師評級是多少？
The latest analyst rating for Immutep (NASDAQ: IMMP) was provided by Baird, and Immutep initiated their outperform rating.
貝爾德提供了對Immutep(納斯達克代碼：IMMP)的最新分析師評級，Immutep啟動了對其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Immutep (IMMP)?
Immutep(IMMP)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immutep, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immutep was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公開財務報表，與Immutep的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Immutep的上一次評級是在2023年8月2日提交的，所以你應該預計下一次評級將在2024年8月2日左右的某個時候公佈。
Is the Analyst Rating Immutep (IMMP) correct?
分析師評級Immutep(IMMP)正確嗎？
While ratings are subjective and will change, the latest Immutep (IMMP) rating was a initiated with a price target of $0.00 to $7.00. The current price Immutep (IMMP) is trading at is $2.13, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的Immutep(IMMP)評級是以0.00美元至7.00美元的目標價啟動的。Immutep(IMMP)目前的交易價格為2.13美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧